Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En studie av MK-1084 Plus Pembrolizumab (MK-3475) hos deltakere med KRAS G12C-mutant, metastatisk ikke-småcellet lungekreft (NSCLC) med programmert celledødsligand 1 (PD-L1) tumorproporsjonsscore (TPS) ≥50 % (MK-1084-004)

22. oktober 2026 oppdatert av: Merck Sharp & Dohme LLC

En fase 3, randomisert, dobbeltblind, multisenterstudie av MK-1084 i kombinasjon med Pembrolizumab sammenlignet med Pembrolizumab Plus Placebo som førstelinjebehandling av deltakere med KRAS G12C-mutant, metastatisk NSCLC med PD-L1 TPS ≥50 %

This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There is one primary study hypothesis:

Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR).

Studieoversikt

Detaljert beskrivelse

Per Protocol Amendment 04, overall survival (OS) was moved to be a secondary outcome measure. Additionally, no new participants will be offered Second Course treatment for pembrolizumab.

Studietype

Intervensjonell

Registrering (Antatt)

348

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Buenos Aires
      • Berazategui, Buenos Aires, Argentina, B1884BBF
        • Rekruttering
        • Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +541142262013
      • CABA, Buenos Aires, Argentina, C1019ABS
        • Fullført
        • AUSTRAL MEDICAL CENTER ( Site 0302)
      • CABA, Buenos Aires, Argentina, C1426AGE
        • Rekruttering
        • Centro Oncologico Korben ( Site 0304)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 1157507952
      • Mar del Plata, Buenos Aires, Argentina, B7600FZO
        • Rekruttering
        • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 02234963224
    • Río Negro Province
      • Viedma, Río Negro Province, Argentina, R8500ACE
        • Rekruttering
        • Clinica Viedma S. A ( Site 0307)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +54 2920 42-8700
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, S2000DEJ
        • Rekruttering
        • Fundacion Estudios Clinicos ( Site 0306)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +543412221472
      • Rosario, Santa Fe Province, Argentina, S2000DSV
        • Rekruttering
        • Sanatorio Parque ( Site 0301)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +54341420-0222
    • New South Wales
      • Camperdown, New South Wales, Australia, 2050
        • Rekruttering
        • Chris O'Brien Lifehouse ( Site 3000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61285140140
    • Queensland
      • Urraween, Queensland, Australia, 4655
        • Rekruttering
        • Cancer Care Service Hervey Bay ( Site 3003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +610743256110
    • Victoria
      • Frankston, Victoria, Australia, 3199
        • Rekruttering
        • Frankston Hospital ( Site 3002)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61397847777
    • Western Australia
      • Nedlands, Western Australia, Australia, 6009
        • Rekruttering
        • One Clinical Research ( Site 3001)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61862799466
      • Rio de Janeiro, Brasil, 22775-001
        • Rekruttering
        • Americas ( Site 0431)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +552133852088
      • Rio de Janeiro, Brasil, 20230-130
        • Rekruttering
        • Instituto Nacional de Câncer - INCA ( Site 0446)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +552132076564
    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brasil, 30380-472
        • Rekruttering
        • Hospital Mario Penna ( Site 0436)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +553132999543
    • Pernambuco
      • Recife, Pernambuco, Brasil, 50040-000
        • Rekruttering
        • Hospital de Câncer de Recife ( Site 0447)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +558132178084
    • Piauí
      • Teresina, Piauí, Brasil, 64049-200
        • Fullført
        • Oncoclínica Oncologistas Associados ( Site 0441)
    • Rio Grande do Norte
      • Natal, Rio Grande do Norte, Brasil, 59062-000
        • Rekruttering
        • Liga Norte Riograndense Contra o Câncer ( Site 0439)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +558440095595
    • Rio Grande do Sul
      • Ijuí, Rio Grande do Sul, Brasil, 98700 000
        • Rekruttering
        • Hospital de Caridade de Ijuí ( Site 0438)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +5555991221138
      • Passo Fundo, Rio Grande do Sul, Brasil, 99010-260
        • Rekruttering
        • Hospital de Clínicas de Passo Fundo ( Site 0442)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +5554981271411
      • Porto Alegre, Rio Grande do Sul, Brasil, 90050-170
        • Rekruttering
        • Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +555132148143
    • São Paulo
      • Barretos, São Paulo, Brasil, 14784-400
        • Rekruttering
        • Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +551733216638
      • Pleven, Bulgaria, 5804
        • Rekruttering
        • MHAT - Heart and Brain ( Site 1006)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +35988030371
      • Plovdiv, Bulgaria, 4000
        • Rekruttering
        • Medical Center Futuremeds ( Site 1007)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +359886744494
      • Plovdiv, Bulgaria, 4004
        • Rekruttering
        • Complex Oncology Center - Plovdiv EOOD ( Site 1003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +359 32 277 240
    • Pazardzhik
      • Panagyurishte, Pazardzhik, Bulgaria, 4500
        • Rekruttering
        • MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +35935788581
    • Sofia (stolitsa)
      • Sofia, Sofia (stolitsa), Bulgaria, 1632
        • Rekruttering
        • Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +35929049100
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3E 0V9
        • Rekruttering
        • CancerCare Manitoba ( Site 0210)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 204-787-4156
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2Y9
        • Rekruttering
        • QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 9024737964
    • Ontario
      • Hamilton, Ontario, Canada, L8V 5C2
        • Rekruttering
        • Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 9053879495
      • Toronto, Ontario, Canada, M4N 3M5
        • Rekruttering
        • Sunnybrook Research Institute ( Site 0206)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 4164805000x687435
    • Quebec
      • Montreal, Quebec, Canada, H3T 1M5
        • Rekruttering
        • St. Marys Hospital Center ( Site 0204)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 5143453511
      • Trois-Rivières, Quebec, Canada, G8Z 3R9
        • Rekruttering
        • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 8196973333x63238
    • Maule Region
      • Talca, Maule Region, Chile, 3465584
        • Rekruttering
        • Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +56947532700
    • Region M. de Santiago
      • Santiago, Region M. de Santiago, Chile, 7500713
        • Rekruttering
        • Orlandi Oncologia-Oncology ( Site 0503)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +56226057491
      • Santiago, Region M. de Santiago, Chile, 7500921
        • Rekruttering
        • FALP-UIDO ( Site 0501)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +56224205098
      • Santiago, Region M. de Santiago, Chile, 8420383
        • Rekruttering
        • Bradfordhill-Clinical Area ( Site 0504)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +56229490970
      • Santiago, Region M. de Santiago, Chile, 7560913
        • Rekruttering
        • Centro de Oncología de Precisión ( Site 0502)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56991612199
    • Cesar Department
      • Valledupar, Cesar Department, Colombia, 200001
        • Rekruttering
        • Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +573122354788
    • Cundinamarca
      • Bogota, Cundinamarca, Colombia, 110111
        • Rekruttering
        • Clinica Oncologica Colsubsidio ( Site 4003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +573142059194
    • Risaralda Department
      • Pereira, Risaralda Department, Colombia, 660001
        • Rekruttering
        • Oncologos del Occidente ( Site 4005)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +57 3187715522
    • Valle del Cauca Department
      • Cali, Valle del Cauca Department, Colombia, 76001
        • Rekruttering
        • Hemato Oncologos SA ( Site 4002)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +573167711932
      • San José, Costa Rica, 10103
        • Rekruttering
        • Onco Tech, S.A. ( Site 4102)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +50622586260
    • National Capital Region
      • Pasig, National Capital Region, Filippinene, 1600
        • Rekruttering
        • The Medical City ( Site 3507)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: (02)6356789 loc 5083
      • Quezon City, National Capital Region, Filippinene, 1100
        • Rekruttering
        • Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +632 892 46101*1309
      • Quezon City, National Capital Region, Filippinene, 1102
        • Rekruttering
        • ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +63287230101
      • Quezon City, National Capital Region, Filippinene, 1100
        • Aktiv, ikke rekrutterende
        • Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
    • California
      • Bakersfield, California, Forente stater, 93309
        • Rekruttering
        • CBCC Global Research, Inc. ( Site 0123)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 661-322-2206
      • Beverly Hills, California, Forente stater, 90211
        • Rekruttering
        • Beverly Hills Cancer Center ( Site 0116)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 310-432-8955
    • Connecticut
      • Stamford, Connecticut, Forente stater, 06902
        • Rekruttering
        • Stamford Hospital ( Site 0136)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 877-233-9355
    • Florida
      • Miami Beach, Florida, Forente stater, 33140
        • Fullført
        • Mount Sinai Cancer Center ( Site 0137)
    • Illinois
      • Skokie, Illinois, Forente stater, 60077
        • Rekruttering
        • Orchard Healthcare Research Inc. ( Site 0115)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 224-534-7580
    • Missouri
      • Kansas City, Missouri, Forente stater, 64108
        • Rekruttering
        • Truman Medical Center ( Site 0126)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 816-404-4093
      • Springfield, Missouri, Forente stater, 65807
        • Rekruttering
        • Cox Medical Center North ( Site 0133)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 417-875-3000
    • Montana
      • Billings, Montana, Forente stater, 59102
        • Rekruttering
        • St. Vincent Frontier Cancer Center-Research ( Site 0105)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 402-238-6685
    • New Jersey
      • Morristown, New Jersey, Forente stater, 07960
        • Fullført
        • Atlantic Health System Morristown Medical Center ( Site 0121)
    • New York
      • Albany, New York, Forente stater, 12206
        • Rekruttering
        • New York Oncology Hematology, P.C. ( Site 0132)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 518-489-3612
    • Ohio
      • Cincinnati, Ohio, Forente stater, 45219
        • Rekruttering
        • University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 513-556-6000
      • Kettering, Ohio, Forente stater, 45429
        • Fullført
        • Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
    • Pennsylvania
      • Lancaster, Pennsylvania, Forente stater, 17601
        • Rekruttering
        • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 717-544-9400
    • Texas
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Oncology Consultants P.A. ( Site 0113)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 713-600-0900
    • Wisconsin
      • Madison, Wisconsin, Forente stater, 53715
        • Rekruttering
        • Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 608-410-2767
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, Frankrike, 06000
        • Rekruttering
        • Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33492038281
    • Bourgogne-Franche-Comté
      • Dijon, Bourgogne-Franche-Comté, Frankrike, 21000
        • Rekruttering
        • Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33380293772
    • Gard
      • Nîmes, Gard, Frankrike, 30029
        • Rekruttering
        • Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33 4 66 68 32 21
    • Nord
      • Valenciennes, Nord, Frankrike, 59304
        • Rekruttering
        • Clinique Teissier Groupe ( Site 1100)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33327142337
    • Puy-de-Dome
      • Clermont-Ferrand, Puy-de-Dome, Frankrike, 63003
        • Rekruttering
        • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33473278005
    • Vaucluse
      • Avignon, Vaucluse, Frankrike, 84000
        • Rekruttering
        • Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33432753333
    • Île-de-France Region
      • Boulogne-Billancourt, Île-de-France Region, Frankrike, 92100
        • Rekruttering
        • Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33149095806
      • Tbilisi, Georgia, 0112
        • Rekruttering
        • Todua Clinic, LLC ( Site 1204)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995322575757
      • Tbilisi, Georgia, 0162
        • Rekruttering
        • New Hospitals ( Site 1200)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995 598 988 566
      • Tbilisi, Georgia, 0177
        • Rekruttering
        • Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995322430100
      • Tbilisi, Georgia, 0102
        • Rekruttering
        • American Hospital Network LLC ( Site 1208)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995 571 300 705
      • Tbilisi, Georgia, 1206
        • Fullført
        • Tbilisi Institute of Medicine ( Site 1206)
      • Tbilisi, Georgia, 0144
        • Fullført
        • TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
      • Tbilisi, Georgia, 0159
        • Rekruttering
        • "Institute of Clinical Oncology" LTD ( Site 1210)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995599406920
    • Adjara
      • Batumi, Adjara, Georgia, 6000
        • Rekruttering
        • High Technology Hospital Medcenter ( Site 1203)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995596226060
      • Tbilisi, Adjara, Georgia, 0186
        • Rekruttering
        • Caucasus Medical Centre ( Site 1202)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995 597 550 140
    • Imereti
      • Kutaisi, Imereti, Georgia, 4600
        • Rekruttering
        • JSC "Vian" ( Site 1211)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +995599705858
      • Thessaloniki, Hellas, 570 10
        • Rekruttering
        • G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0030 231330787476
      • Thessaloniki, Hellas, 570 01
        • Rekruttering
        • European Interbalkan Medical Center ( Site 1404)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302310380000
    • Achaia
      • Pátrai, Achaia, Hellas, 26504
        • Rekruttering
        • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302610999791
    • Attica
      • Athens, Attica, Hellas, 115 27
        • Rekruttering
        • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302107700220
      • Athens, Attica, Hellas, 115 22
        • Rekruttering
        • Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302106409501
      • Marousi, Attica, Hellas, 151 25
        • Rekruttering
        • Athens Medical Center ( Site 1406)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302107464642
      • Piraeus, Attica, Hellas, 185 37
        • Rekruttering
        • Metaxa Cancer Hospital of Piraeus ( Site 1408)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302132079225
    • Thessaly
      • Larissa, Thessaly, Hellas, 411 10
        • Rekruttering
        • University General Hospital of Larissa-Oncology Clinic ( Site 1403)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +302413502124
    • Maharashtra
      • Mumbai, Maharashtra, India, 400012
        • Rekruttering
        • Tata Memorial Hospital ( Site 3205)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 02224177000
      • Mumbai, Maharashtra, India, 400004
        • Aktiv, ikke rekrutterende
        • Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
    • National Capital Territory of Delhi
      • New Delhi, National Capital Territory of Delhi, India, 110076
        • Rekruttering
        • Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +919426166688
      • New Delhi, National Capital Territory of Delhi, India, 110029
        • Rekruttering
        • AIIMS New Delhi Dept of Medicine ( Site 3206)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +91-9650629370
      • Padova, Italia, 35131
        • Rekruttering
        • IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390498215649
    • Campania
      • Naples, Campania, Italia, 80131
        • Rekruttering
        • Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390811777029
    • Emilia-Romagna
      • Ravenna, Emilia-Romagna, Italia, 48121
        • Rekruttering
        • Ospedale Santa Maria delle Croci ( Site 1606)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390544285247
    • Friuli Venezia Giulia
      • Aviano, Friuli Venezia Giulia, Italia, 33081
        • Rekruttering
        • CRO-IRCCS-Clinical Oncology ( Site 1605)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390434309464
    • Lazio
      • Rome, Lazio, Italia, 00168
        • Rekruttering
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00390630156318
    • Lombardy
      • Milan, Lombardy, Italia, 20133
        • Rekruttering
        • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390223903829
      • Milan, Lombardy, Italia, 20141
        • Rekruttering
        • Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390257489482
    • Napoli
      • Naples, Napoli, Italia, 80131
        • Rekruttering
        • A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0817062652
    • Roma
      • Rome, Roma, Italia, 00144
        • Rekruttering
        • Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390652662205
    • Tuscany
      • Livorno, Tuscany, Italia, 57124
        • Rekruttering
        • Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00390586223416
      • Chiba, Japan, 260-8677
        • Rekruttering
        • Chiba University Hospital ( Site 3322)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-43-222-7171
      • Hiroshima, Japan, 730-8518
        • Rekruttering
        • Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-82-221-2291
      • Kumamoto, Japan, 861-4193
        • Rekruttering
        • Saiseikai Kumamoto Hospital ( Site 3318)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-96-351-8000
      • Niigata, Japan, 951-8520
        • Rekruttering
        • Niigata University Medical & Dental Hospital ( Site 3323)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-25-223-6161
      • Osaka, Japan, 545-8586
        • Rekruttering
        • Osaka Metropolitan University Hospital ( Site 3321)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-6-6645-2121
    • Aichi-ken
      • Nagoya, Aichi-ken, Japan, 466-8560
        • Rekruttering
        • Nagoya University Hospital ( Site 3309)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-52-741-2111
      • Toyoake, Aichi-ken, Japan, 470-1192
        • Rekruttering
        • Fujita Health University Hospital ( Site 3310)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-562-93-2111
    • Chiba
      • Kashiwa, Chiba, Japan, 277-8577
        • Rekruttering
        • National Cancer Center Hospital East ( Site 3303)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-4-7133-1111
    • Ehime
      • Matsuyam, Ehime, Japan, 719-0280
        • Rekruttering
        • National Hospital Organization Shikoku Cancer Center ( Site 3315)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-89-999-1111
    • Fukuoka
      • Fukuoka, Fukuoka, Japan, 811-1395
        • Rekruttering
        • National Hospital Organization Kyushu Cancer Center ( Site 3316)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-92-541-3231
      • Kurume, Fukuoka, Japan, 830-0011
        • Rekruttering
        • Kurume University Hospital ( Site 3317)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-942-35-3311
    • Gunma
      • Ōta, Gunma, Japan, 373-8550
        • Rekruttering
        • Gunma Prefectural Cancer Center ( Site 3302)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-276-38-0771
    • Hokkaido
      • Sapporo, Hokkaido, Japan, 060-8543
        • Rekruttering
        • Sapporo Medical University Hospital ( Site 3324)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-11-611-2111
    • Ishikawa-ken
      • Kanazawa, Ishikawa-ken, Japan, 920-8641
        • Rekruttering
        • Kanazawa University Hospital ( Site 3308)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-76-265-2000
    • Kanagawa
      • Kawasaki, Kanagawa, Japan, 216-8511
        • Rekruttering
        • St. Marianna University Hospital ( Site 3320)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-44-977-8111
    • Mie-ken
      • Matsusaka, Mie-ken, Japan, 515-8544
        • Rekruttering
        • Saiseikai Matsusaka Municipal Hospital ( Site 3311)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-598-23-1515
    • Miyagi
      • Natori-shi, Miyagi, Japan, 981-1293
        • Rekruttering
        • Miyagi Cancer Center ( Site 3301)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-22-384-3151
      • Sendai, Miyagi, Japan, 981-0914
        • Rekruttering
        • Sendai Kousei Hospital ( Site 3300)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-22-222-6181
    • Osaka
      • Hirakata, Osaka, Japan, 573-1191
        • Rekruttering
        • Kansai Medical University Hospital ( Site 3312)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-72-804-0101
      • Takatsuki, Osaka, Japan, 569-8686
        • Rekruttering
        • Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-72-683-1221
    • Saitama
      • Kitaadachi-gun, Saitama, Japan, 362-0806
        • Rekruttering
        • Saitama Prefectural Cancer Center ( Site 3304)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-48-722-1111
    • Tokyo
      • Bunkyo, Tokyo, Japan, 113-8603
        • Rekruttering
        • Nippon Medical School Hospital ( Site 3306)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3822-2131
      • Shinjuku, Tokyo, Japan, 160-0023
        • Rekruttering
        • Tokyo Medical University Hospital ( Site 3307)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3342-6111
      • Shinjuku, Tokyo, Japan, 162-8655
        • Rekruttering
        • National Center for Global Health and Medicine ( Site 3305)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3202-7181
      • Ōta-ku, Tokyo, Japan, 143-8541
        • Rekruttering
        • Toho University Omori Medical Center ( Site 3319)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3762-4151
    • Anhui
      • Hefei, Anhui, Kina, 230031
        • Aktiv, ikke rekrutterende
        • Anhui Provincial Cancer Hospital ( Site 3136)
    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina, 100142
        • Aktiv, ikke rekrutterende
        • Beijing Cancer hospital ( Site 3133)
      • Beijing, Beijing Municipality, Kina, 100142
        • Aktiv, ikke rekrutterende
        • Beijing Cancer hospital ( Site 3134)
      • Beijing, Beijing Municipality, Kina, 100730
        • Aktiv, ikke rekrutterende
        • Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
      • Beijing, Beijing Municipality, Kina, 101149
        • Aktiv, ikke rekrutterende
        • Beijing Chest Hospital,Capital Medical University ( Site 3104)
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Kina, 400030
        • Aktiv, ikke rekrutterende
        • Chongqing University Cancer Hospital ( Site 3119)
      • Chongqing, Chongqing Municipality, Kina, 400042
        • Fullført
        • Army Medical Center of People's Liberation Army ( Site 3142)
    • Fujian
      • Fuzhou, Fujian, Kina, 350014
        • Aktiv, ikke rekrutterende
        • Fujian Cancer Hospital ( Site 3127)
      • Xiamen, Fujian, Kina, 361003
        • Aktiv, ikke rekrutterende
        • The First Affiliated hospital of Xiamen University ( Site 3148)
    • Guangdong
      • Guangzhou, Guangdong, Kina, 510160
        • Fullført
        • The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
      • Guangzhou, Guangdong, Kina, 510515
        • Aktiv, ikke rekrutterende
        • Southern Medical University Nanfang Hospital ( Site 3128)
      • Guangzhou, Guangdong, Kina, 510555
        • Fullført
        • Sun Yat-sen University Cancer Center ( Site 3137)
    • Heilongjiang
      • Harbin, Heilongjiang, Kina, 150081
        • Aktiv, ikke rekrutterende
        • Harbin Medical University Cancer Hospital ( Site 3123)
      • Jiamusi, Heilongjiang, Kina, 154007
        • Aktiv, ikke rekrutterende
        • JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
    • Henan
      • Zhengzhou, Henan, Kina, 450008
        • Aktiv, ikke rekrutterende
        • Henan Cancer Hospital ( Site 3149)
    • Hubei
      • Wuhan, Hubei, Kina, 430000
        • Aktiv, ikke rekrutterende
        • Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
      • Wuhan, Hubei, Kina, 430079
        • Aktiv, ikke rekrutterende
        • Hubei Cancer Hospital ( Site 3126)
    • Hunan
      • Changsha, Hunan, Kina, 410011
        • Fullført
        • The Second Xiangya Hospital of Central South University ( Site 3130)
      • Changsha, Hunan, Kina, 410013
        • Aktiv, ikke rekrutterende
        • Hunan Cancer Hospital ( Site 3141)
    • Jiangsu
      • Nanjing, Jiangsu, Kina, 210008
        • Aktiv, ikke rekrutterende
        • Nanjing Gulou Hospital ( Site 3122)
      • Nanjing, Jiangsu, Kina, 210012
        • Fullført
        • Nanjing First Hospital ( Site 3154)
      • Suzhou, Jiangsu, Kina, 215006
        • Fullført
        • The First Affiliated Hospital of Soochow University ( Site 3146)
      • Wuxi, Jiangsu, Kina, 214122
        • Aktiv, ikke rekrutterende
        • Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
    • Jiangxi
      • Nanchang, Jiangxi, Kina, 330000
        • Fullført
        • The Second Affiliated Hospital of Nanchang University ( Site 3139)
      • Nanchang, Jiangxi, Kina, 330006
        • Aktiv, ikke rekrutterende
        • The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
    • Jilin
      • Changchun, Jilin, Kina, 130012
        • Aktiv, ikke rekrutterende
        • Jilin Province Tumor Hospital ( Site 3107)
    • Shaanxi
      • Xi'an, Shaanxi, Kina, 710000
        • Fullført
        • The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
    • Shandong
      • Jinan, Shandong, Kina, 250117
        • Aktiv, ikke rekrutterende
        • Shandong Cancer Hospital ( Site 3116)
      • Linyi, Shandong, Kina, 276001
        • Aktiv, ikke rekrutterende
        • LinYi Cancer Hospital ( Site 3111)
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200030
        • Aktiv, ikke rekrutterende
        • Shanghai Chest Hospital ( Site 3100)
      • Shanghai, Shanghai Municipality, Kina, 200032
        • Aktiv, ikke rekrutterende
        • Fudan University Shanghai Cancer Center ( Site 3144)
      • Shanghai, Shanghai Municipality, Kina, 200032
        • Aktiv, ikke rekrutterende
        • Zhongshan Hospital,Fudan University ( Site 3143)
    • Shanxi
      • Taiyuan, Shanxi, Kina, 030000
        • Aktiv, ikke rekrutterende
        • Shanxi Cancer Hospital ( Site 3131)
      • Xian, Shanxi, Kina, 710038
        • Fullført
        • The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
      • Xian, Shanxi, Kina, 710038
        • Aktiv, ikke rekrutterende
        • The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
    • Sichuan
      • Chengdu, Sichuan, Kina, 610000
        • Aktiv, ikke rekrutterende
        • West China Hospital, Sichuan University ( Site 3140)
      • Chengdu, Sichuan, Kina, 610031
        • Aktiv, ikke rekrutterende
        • The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
      • Chengdu, Sichuan, Kina, 610042
        • Aktiv, ikke rekrutterende
        • Sichuan Cancer hospital. ( Site 3109)
      • Neijiang, Sichuan, Kina, 641000
        • Aktiv, ikke rekrutterende
        • The Second People's Hospital of Neijiang ( Site 3105)
    • Xinjiang
      • Ürümqi, Xinjiang, Kina, 830000
        • Fullført
        • Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
    • Yunnan
      • Kunming, Yunnan, Kina, 650107
        • Aktiv, ikke rekrutterende
        • Yunnan Province Cancer Hospital ( Site 3153)
    • Zhejiang
      • Hangzhou, Zhejiang, Kina, 310006
        • Aktiv, ikke rekrutterende
        • The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
      • Hangzhou, Zhejiang, Kina, 310016
        • Aktiv, ikke rekrutterende
        • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
      • Linhai, Zhejiang, Kina, 317000
        • Aktiv, ikke rekrutterende
        • Taizhou Hospital of Zhejiang Province ( Site 3145)
      • Wenzhou, Zhejiang, Kina, 325015
        • Aktiv, ikke rekrutterende
        • The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
      • México, Mexico, 14080
        • Rekruttering
        • Instituto Nacional de Cancerologia. ( Site 0608)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +525556280400
      • Oaxaca City, Mexico, 68000
        • Rekruttering
        • Oaxaca Site Management Organization S.C. ( Site 0603)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +529515147056
    • Mexico City
      • Mexico City, Mexico City, Mexico, 06700
        • Rekruttering
        • Arké SMO S.A. de C.V. ( Site 0602)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 5533345856
    • Nuevo León
      • Monterrey, Nuevo León, Mexico, 66460
        • Rekruttering
        • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +528180883663
      • Utrecht, Nederland, 3584 CX
        • Rekruttering
        • Universitair Medisch Centrum Utrecht ( Site 1704)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00318875555555
    • Gelderland
      • Ede, Gelderland, Nederland, 6716 RP
        • Rekruttering
        • Ziekenhuis Gelderse Vallei ( Site 1705)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0318435499
      • Harderwijk, Gelderland, Nederland, 3844 DG
        • Rekruttering
        • Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0031341463504
    • Overijssel
      • Hengelo, Overijssel, Nederland, 7555 DL
        • Rekruttering
        • Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +31887087878
      • Zwolle, Overijssel, Nederland, 8025 AB
        • Rekruttering
        • Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0031886243254
      • Auckland, New Zealand, 1023
        • Rekruttering
        • Auckland City Hospital ( Site 3400)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +6493074949
      • Lima, Peru, 15036
        • Rekruttering
        • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 511 2241598 anex 121
    • Lesser Poland Voivodeship
      • Gorlice, Lesser Poland Voivodeship, Polen, 38-300
        • Fullført
        • Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
      • Krakow, Lesser Poland Voivodeship, Polen, 30-727
        • Fullført
        • Pratia MCM Krakow ( Site 1808)
    • Lublin Voivodeship
      • Lublin, Lublin Voivodeship, Polen, 20-090
        • Rekruttering
        • Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48 814485180
    • Masovian Voivodeship
      • Warsaw, Masovian Voivodeship, Polen, 02-781
        • Rekruttering
        • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1800)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48225462336
    • Podkarpackie Voivodeship
      • Przemyśl, Podkarpackie Voivodeship, Polen, 37-700
        • Rekruttering
        • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48166775000
    • Warmian-Masurian Voivodeship
      • Olsztyn, Warmian-Masurian Voivodeship, Polen, 10-357
        • Rekruttering
        • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48895322978
      • Brasov, Romania, 500052
        • Rekruttering
        • SC ONCO CARD SRL ( Site 1995)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +40268 994
      • Bucharest, Romania, 077190
        • Rekruttering
        • SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +40722927377
      • Cluj-Napoca, Romania, 400015
        • Rekruttering
        • Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +40264598362
      • Suceava, Romania, 720214
        • Rekruttering
        • Sigmedical Services SRL ( Site 1997)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4 0330 803 483
    • Bucharest
      • Bucharest, Bucharest, Romania, 020335
        • Rekruttering
        • Centrul de Diagnostic si Tratament Provita. ( Site 1992)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4021.9432
    • Dolj
      • Craiova, Dolj, Romania, 200542
        • Rekruttering
        • Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +40731604432
    • Timiș County
      • Timișoara, Timiș County, Romania, 300239
        • Rekruttering
        • Cabinet Medical Oncomed ( Site 1998)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +40356460995
      • Barcelona, Spania, 08035
        • Rekruttering
        • Hospital Universitari Vall d Hebron ( Site 2010)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34 932 543 450
      • Madrid, Spania, 28040
        • Rekruttering
        • Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 34915504800x253900
      • Madrid, Spania, 28006
        • Rekruttering
        • Hospital Universitario La Princesa ( Site 2020)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34915202200
      • Málaga, Spania, 29010
        • Rekruttering
        • Hospital Universitario Virgen de la Victoria ( Site 2021)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0034671594566
      • Seville, Spania, 41009
        • Rekruttering
        • Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 34954712941
    • Barcelona
      • Vic, Barcelona, Spania, 08500
        • Rekruttering
        • H. General de Vic ( Site 2022)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34937027732
    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spania, 35001
        • Rekruttering
        • Hospital Insular de Gran Canaria-Oncology ( Site 2019)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34 928441738
    • Madrid, Comunidad de
      • Leganés, Madrid, Comunidad de, Spania, 28911
        • Rekruttering
        • Hospital Universitario Severo Ochoa ( Site 2024)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34914818000
      • Madrid, Madrid, Comunidad de, Spania, 28009
        • Rekruttering
        • HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34 915868115
    • Malaga
      • Málaga, Malaga, Spania, 29011
        • Rekruttering
        • H.R.U Málaga - Hospital General-Oncology ( Site 2014)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34 951308130
    • Buckinghamshire
      • Milton Keynes, Buckinghamshire, Storbritannia, MK6 5LD
        • Rekruttering
        • Milton Keynes Hospital ( Site 2304)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 01908 997609
    • Devon
      • Exeter, Devon, Storbritannia, EX2 5DW
        • Rekruttering
        • Royal Devon & Exeter Hospital-Oncology ( Site 2302)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +44 (0) 1392 402869
      • Incheon, Sør -Korea, 22332
        • Rekruttering
        • Inha University Hospital ( Site 3610)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82328901038
      • Seoul, Sør -Korea, 02447
        • Rekruttering
        • Kyung Hee University Hospital ( Site 3605)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-2-958-8511
      • Seoul, Sør -Korea, 08308
        • Rekruttering
        • Korea University Guro Hospital ( Site 3601)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82226261914
      • Seoul, Sør -Korea, 03312
        • Rekruttering
        • The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82220304340
      • Seoul, Sør -Korea, 02841
        • Rekruttering
        • Korea University Anam Hospital ( Site 3609)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +8229206409
    • Incheon
      • Bupyeong-gu, Incheon, Sør -Korea, 21431
        • Rekruttering
        • The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82-32-280-6474
    • Jeonranamdo
      • Hwasun, Jeonranamdo, Sør -Korea, 58128
        • Fullført
        • Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
    • Kyonggi-do
      • Suwon, Kyonggi-do, Sør -Korea, 16247
        • Rekruttering
        • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-31-244-7983
    • Kyongsangnam-do
      • Yangsan, Kyongsangnam-do, Sør -Korea, 50612
        • Rekruttering
        • Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82-55-360-1415
    • Taegu-Kwangyokshi
      • Daegu, Taegu-Kwangyokshi, Sør -Korea, 42415
        • Rekruttering
        • Yeungnam University Hospital ( Site 3607)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82536203848
      • Daegu, Taegu-Kwangyokshi, Sør -Korea, 42601
        • Rekruttering
        • Keimyung University Dongsan Hospital ( Site 3611)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82532587737
    • Taejon-Kwangyokshi
      • Junggu, Taejon-Kwangyokshi, Sør -Korea, 35015
        • Rekruttering
        • Chungnam national university hospital ( Site 3602)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-42-257-5753
      • Adana, Tyrkia (Türkiye), 01140
        • Rekruttering
        • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 322 456 19 00
      • Ankara, Tyrkia (Türkiye), 06010
        • Rekruttering
        • SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +905058726378
      • Ankara, Tyrkia (Türkiye), 06230
        • Rekruttering
        • Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 312 305 10 80
      • Ankara, Tyrkia (Türkiye), 06520
        • Rekruttering
        • Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +903122536666
      • Ankara, Tyrkia (Türkiye), 06800
        • Rekruttering
        • Ankara Bilkent Şehir Hastanesi ( Site 2100)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +903125526000
      • Istanbul, Tyrkia (Türkiye), 34214
        • Rekruttering
        • Medipol Mega Universite Hastanesi-oncology ( Site 2105)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +902124447044
      • Istanbul, Tyrkia (Türkiye), 34722
        • Rekruttering
        • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +902166065200
      • Sakarya, Tyrkia (Türkiye), 54290
        • Rekruttering
        • Sakarya Training and Research Hospital ( Site 2109)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +902648884000
    • İzmir
      • Balçova, İzmir, Tyrkia (Türkiye), 35340
        • Rekruttering
        • Dokuz Eylul Universitesi Hastanesi ( Site 2108)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +902323434343
      • Bornova, İzmir, Tyrkia (Türkiye), 35100
        • Rekruttering
        • Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +905322202675
    • Baden-Wurttemberg
      • Stuttgart, Baden-Wurttemberg, Tyskland, 70199
        • Rekruttering
        • Marienhospital Stuttgart ( Site 1302)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +49711064893273
    • Mecklenburg-Vorpommern
      • Greifswald, Mecklenburg-Vorpommern, Tyskland, 17489
        • Rekruttering
        • Universitätsmedizin Greifswald ( Site 1308)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4938348622006
    • North Rhine-Westphalia
      • Bielefeld, North Rhine-Westphalia, Tyskland, 33611
        • Rekruttering
        • Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0521 772 75504
      • Solingen, North Rhine-Westphalia, Tyskland, 42699
        • Rekruttering
        • Krankenhaus Bethanien ( Site 1303)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +49212636661
    • Cherkasy Oblast
      • Cherkasy, Cherkasy Oblast, Ukraina, 18009
        • Fullført
        • COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
    • Chernivetska Oblast
      • Chernivtsi, Chernivetska Oblast, Ukraina, 58013
        • Rekruttering
        • Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380955077568
    • Dnipropetrovsk Oblast
      • Kryvyi Rih, Dnipropetrovsk Oblast, Ukraina, 50000
        • Rekruttering
        • Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380973567855
    • Ivano-Frankivsk Oblast
      • Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraina, 76018
        • Rekruttering
        • Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380978411455
    • Kirovohrad Oblast
      • Kropyvnytskyi, Kirovohrad Oblast, Ukraina, 25011
        • Rekruttering
        • Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380508412400
    • Kyivska Oblast
      • Kiev, Kyivska Oblast, Ukraina, 03022
        • Rekruttering
        • Medical Center "MedOffice Group" ( Site 2219)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380503858689
      • Kyiv, Kyivska Oblast, Ukraina, 03039
        • Rekruttering
        • LLC Clinic Verum Expert ( Site 2223)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380443835959
    • Lviv Oblast
      • Lviv, Lviv Oblast, Ukraina, 79059
        • Rekruttering
        • Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380506749772
    • Rivne Oblast
      • Rivne, Rivne Oblast, Ukraina, 33007
        • Fullført
        • Rivne Regional Clinical Hospital ( Site 2205)
      • Rivne, Rivne Oblast, Ukraina, 33010
        • Rekruttering
        • ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380362633075
    • Vinnytsia Oblast
      • Vinnytsia, Vinnytsia Oblast, Ukraina, 21029
        • Rekruttering
        • Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380953105783
    • Volyn Oblast
      • Lutsk, Volyn Oblast, Ukraina, 43018
        • Rekruttering
        • ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +380503782998
      • Vienna, Østerrike, 1210
        • Rekruttering
        • Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0043 1 27700 72212
    • Styria
      • Graz, Styria, Østerrike, 8036
        • Rekruttering
        • Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 004331638512183

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

The main inclusion and exclusion criteria include but are not limited to the following:

Inclusion Criteria:

  • Has histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC)
  • Has newly diagnosed Stage IIIB/IIIC NSCLC, not eligible for curative resection or curative chemotherapy/radiation as determined by a multidisciplinary tumor board and/or by radiation oncologist, surgeon, and medical oncologist or Stage IV (M1a, M1b, or M1c) by American Joint Committee on Cancer (AJCC) Staging Manual, Version 8
  • Provides an archival tumor sample (≤5 years) or newly obtained core, incisional, or excisional biopsy or fine needle aspirate (FNA) of a tumor lesion, not previously irradiated to enable central laboratory testing of kirsten rat sarcoma (KRAS) G12C mutation status, programmed cell death ligand 1 (PD-L1) status, and biomarker research
  • If have had adverse events (AEs) due to previous anticancer therapies, must have recovered to < Grade 1 or baseline
  • If human immunodeficiency virus (HIV)-infected, must have well controlled HIV on antiretroviral therapy (ART)
  • If Hepatitis B surface antigen (HBsAg) positive, have received Hepatitis B Virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
  • If a participant has a history of Hepatitis C virus (HCV) infection, HCV viral load is undetectable

Exclusion Criteria:

  • Has diagnosis of small cell lung cancer. For mixed tumors, if small cell elements are present, the participant is ineligible
  • Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease
  • Has known history of, or active, neurologic paraneoplastic syndrome
  • Has an active infection requiring systemic therapy, with exceptions
  • Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
  • Has received prior systemic anticancer therapy for their locally advanced or metastatic NSCLC
  • Has received radiation therapy to the lung that is >30 Gray within 6 months of start of study intervention
  • Has received radiotherapy to non-central nervous system (CNS) disease within 2 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not required corticosteroids, and not have had radiation pneumonitis
  • Has known active CNS metastases and/or carcinomatous meningitis
  • Known additional malignancy that is progressing or has required active treatment within the past 3 years
  • Has active autoimmune disease that has required systemic treatment in the past 2 years
  • Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease
  • Is HIV-infected and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease
  • Has history of allogenic tissue/solid organ transplant
  • Has not fully recovered from any effects of major surgical procedure

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Trippel

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Calderasib with Pembrolizumab

Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and calderasib by oral tablets until discontinuation criterion is met.

IV infusion

Andre navn:
  • MK-3475
  • KEYTRUDA ®

Oral tablets

Andre navn:
  • MK-1084
Aktiv komparator: Placebo with Pembrolizumab

Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and placebo by oral tablets once daily until discontinuation criterion is met.

IV infusion

Andre navn:
  • MK-3475
  • KEYTRUDA ®

Oral tablets

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Progression-Free Survival (PFS)
Tidsramme: Up to approximately 42 months

PFS is defined as the time from randomization until either documented disease progression per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) or death due to any cause, whichever occurs first. PFS as determined by blinded independent central review (BICR) will be presented.

Up to approximately 42 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Survival
Tidsramme: Up to approximately 57 months

OS is defined as the time from randomization to death due to any cause.

Up to approximately 57 months
Objective Response Rate (ORR)
Tidsramme: Up to approximately 42 months

ORR is defined as the percentage of participants with Complete Response or Partial Response per RECIST1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented.

Up to approximately 42 months
Duration of Response (DOR)
Tidsramme: Up to approximately 42 months

For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first.

Up to approximately 42 months
Number of Participants Who Experience One or More Adverse Event (AEs)
Tidsramme: Up to approximately 80 months

An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experience an AE will be presented.

Up to approximately 80 months
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
Tidsramme: Up to approximately 80 months

An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinue study treatment due to an AE will be presented.

Up to approximately 80 months
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) Global Health Status (Item 29) and Quality of Life (Item 30) Combined Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. Higher scores indicate a better overall health status.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Physical Functioning (Items 1-5) Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 1-5 will be presented. Higher scores indicate a better level of functioning.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Role Functioning (Items 6-7) Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 6-7 will be presented. Higher scores indicate a better level of functioning.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-C30 Dyspnea (Item 8) Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. A higher score indicates a worse level of dyspnea.

Baseline and Up to approximately 24 months
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module (EORTC QLQ-LC13) Cough (Item 31) Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. A higher score indicates more frequent coughing.

Baseline and Up to approximately 24 months
Change From Baseline in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Tidsramme: Baseline and Up to approximately 24 months

The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 40 will be presented. A higher score indicates a worse level of chest pain.

Baseline and Up to approximately 24 months
Time to Deterioration (TTD) in EORTC-QLQ-C30 Global Health Status (Item 29) Quality of Life (Item 30) Combined Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in global health status (GHS) and quality of life (QoL) (EORTC QLQ-C30 Items 29 and 30) score. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in GHS and QoL, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Physical Functioning (Items 1-5) Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in physical functioning (EORTC QLQ-C30 Items 1-5) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in physical functioning score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Role Functioning (Items 6-7) Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in role functioning (EORTC QLQ-C30 Items 6 and 7) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in role functioning score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC-QLQ-C30 Dyspnea (Item 8) Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in dyspnea (EORTC QLQ-C30 Item 8) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in dyspnea score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC QLQ-LC13 Cough (Item 31) Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in cough (EORTC QLQ-C13 Item 31) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in cough score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months
TTD in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Tidsramme: Baseline and Up to approximately 24 months

TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in chest pain (EORTC QLQ-C13 Item 40) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline chest pain score, will be presented. A longer TTD indicates a better outcome.

Baseline and Up to approximately 24 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Medical Director, Merck Sharp & Dohme LLC

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

24. mai 2024

Primær fullføring (Antatt)

24. januar 2028

Studiet fullført (Antatt)

18. februar 2031

Datoer for studieregistrering

Først innsendt

28. mars 2024

Først innsendt som oppfylte QC-kriteriene

28. mars 2024

Først lagt ut (Faktiske)

3. april 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

26. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

22. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 1084-004
  • MK-1084-004 (Annen identifikator: MSD)
  • U1111-1296-8093 (Registeridentifikator: UTN)
  • jRCT2031240213 (Registeridentifikator: jRCT)
  • PHRR241128-007796 (Registeridentifikator: PHRR)
  • 2023-507776-42-00 (Registeridentifikator: EU CT)
  • KANDLELIT-004 (Annen identifikator: MSD)
  • 2023 (U.S. NIH-stipend/kontrakt)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere